INNATE PHARMA |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.13 EUR | -0.93% |
|
-8.78% | -18.70% |
| Apr. 15 | Sanofi: progress in hematology trial | CF |
| Apr. 15 | Innate Pharma: progress in hematology trial | CF |
Quotes 5-day view
Real-time Euronext Paris| 2024-04-15 | 2024-04-16 | 2024-04-17 | 2024-04-18 | 2024-04-19 | |
|---|---|---|---|---|---|
| Last | 2.26 € | 2.2 € | 2.16 € | 2.15 € | 2.13 € |
| Volume | 89 612 | 88 136 | 126 844 | 72 009 | 42 364 |
| Change | -3.21% | -2.65% | -1.82% | -0.46% | -0.93% |
| Opening | 2.34 | 2.25 | 2.21 | 2.15 | 2.15 |
| High | 2.34 | 2.28 | 2.21 | 2.18 | 2.16 |
| Low | 2.26 | 2.17 | 2.14 | 2.13 | 2.11 |
Performance
| 1 day | -1.40% | ||
| 1 week | -9.21% | ||
| Current month | -2.97% | ||
| 1 month | -4.29% | ||
| 3 months | -13.47% | ||
| 6 months | -7.42% | ||
| Current year | -19.08% | ||
| 1 year | -26.13% | ||
| 3 years | -42.01% | ||
| 5 years | -64.07% | ||
| 10 years | -71.39% |
Volumes
marketsDaily volume
42 064
Estimated daily volume
78 187
Avg. Volume 20 sessions
74 794
Daily volume ratio
1.05
Avg. Volume 20 sessions
158 563.28
Avg. Volume 20 sessions USD
168 796.95
Record volume 1
14 161 860
Record volume 2
10 742 570
Record volume 3
9 928 481
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
174 101 788
Capitalization (USD)
185 338 317
Net sales (EUR)
61 641 000
Net sales (USD)
65 619 310
Number of employees
179
Sales / Employee (EUR)
344 363
Sales / Employee (USD)
366 588
Free-Float
75.3 %
Free-Float capitalization (EUR)
131 126 833
Free-Float capitalization (USD)
139 589 758
Average Daily Capital Traded
0.09%
Highs and lows
1 week
2.11
2.34
1 month
2.112.39
Current year
2.112.80
1 year
2.113.35
3 years
1.998.30
5 years
1.998.30
10 years
1.9917.85
Indicators
Moving average 5 days
2.22
Moving average 20 days
2.24
Moving average 50 days
2.26
Moving average 100 days
2.35
Price spread / (MMA5)
+4.76%
Price spread / (MMA20)
+5.46%
Price spread / (MMA50)
+6.64%
Price spread / (MMA100)
+10.92%
STIM
RSI 9 days
36.06
RSI 14 days
40.73
Sector Comparison - Other Biotechnology & Medical Research
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -1.40% | -9.21% | -19.08% | -26.13% | 185M | ||
| -0.04% | -4.56% | -1.82% | +12.06% | 41.35B | ||
| -1.31% | -5.83% | +42.44% | -13.17% | 40.38B | ||
| -1.39% | -4.68% | +2.56% | -28.49% | 39.05B | ||
| +3.57% | -1.34% | -12.11% | +3.57% | 26.67B | ||
| -0.07% | -6.58% | +3.09% | +37.06% | 24.07B | ||
| -0.11% | -4.56% | -24.16% | -28.02% | 18.36B | ||
| -2.12% | -6.96% | +22.12% | +95.28% | 11.6B | ||
| -1.10% | -7.66% | -3.74% | +10.45% | 11.68B | ||
| +0.69% | -0.13% | +7.75% | +3.93% | 11.15B | ||
| -0.83% | -9.59% | -19.38% | -26.23% | 9.78B | ||
| +0.61% | -4.13% | -11.84% | -16.41% | 8.74B | ||
| -1.24% | -3.72% | +19.46% | -18.31% | 6.46B | ||
| -.--% | -.--% | - | - | 6.07B | ||
| -2.69% | -4.22% | +24.93% | +47.63% | 5.9B | ||
| -0.24% | -3.98% | -19.33% | +12.18% | 5.95B | ||
| Average | -0.51% | -4.89% | +0.73% | +4.36% | ||
| Weighted average by Cap. | -0.30% | -4.85% | +4.62% | +1.64% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
1efa58011d2c443782c73ff7.F5P7DNEmKXdl4SMMCZyMIbhutGso1KxQqNM_QKoz_yI.JtKYRKZgRz06r0AhYPrPUtpD9l5uscE59-RnBeh6z2xVxKJmsEtaDTaJTA
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 07:36:26 am | 2.12 | 112 | 42,064 |
| 07:36:26 am | 2.12 | 113 | 41,952 |
| 07:20:29 am | 2.12 | 118 | 41,839 |
| 07:17:35 am | 2.14 | 337 | 41,721 |
| 07:17:35 am | 2.14 | 1,000 | 41,384 |
| 07:17:35 am | 2.14 | 211 | 40,384 |
| 07:17:35 am | 2.14 | 452 | 40,173 |
| 06:48:22 am | 2.12 | 69 | 39,721 |
| 06:41:23 am | 2.14 | 48 | 39,652 |
| 06:14:54 am | 2.115 | 211 | 39,604 |
Monthly variations
Annual change
| 2024 | -17.94% | ||
| 2023 | -20.36% | ||
| 2022 | -26.03% | ||
| 2021 | +28.48% | ||
| 2020 | -41.91% | ||
| 2019 | -19.84% | ||
| 2018 | +56.53% | ||
| 2017 | -67.49% | ||
| 2016 | +7.90% | ||
| 2015 | +71.39% | ||
| 2014 | +59.27% | ||
| 2013 | +128.57% | ||
| 2012 | +58.39% | ||
| 2011 | +17.09% | ||
| 2010 | -51.45% | ||
| 2009 | +74.64% | ||
| 2008 | -62.19% | ||
| 2007 | -41.60% | ||
| 2006 | +29.40% |
- Stock Market
- Equities
- IPH Stock
- Quotes Innate Pharma
